Skip to main content

Prevalence of Pretreatment and Acquired HIV-1 Mutations Associated with Resistance to Lamivudine or Rilpivirine: A Systematic Review

Publication ,  Journal Article
Vannappagari, V; Ragone, L; Henegar, C; van Wyk, J; Brown, D; Demarest, J; Quercia, R; Clair, MS; Underwood, M; Gatell, JM; de Ruiter, A; Aboud, M
Published in: Antiviral Therapy
August 2019

Duke Scholars

Published In

Antiviral Therapy

DOI

EISSN

2040-2058

ISSN

1359-6535

Publication Date

August 2019

Volume

24

Issue

6

Start / End Page

393 / 404

Publisher

SAGE Publications

Related Subject Headings

  • Virology
  • 1108 Medical Microbiology
  • 1103 Clinical Sciences
  • 0605 Microbiology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Vannappagari, V., Ragone, L., Henegar, C., van Wyk, J., Brown, D., Demarest, J., … Aboud, M. (2019). Prevalence of Pretreatment and Acquired HIV-1 Mutations Associated with Resistance to Lamivudine or Rilpivirine: A Systematic Review. Antiviral Therapy, 24(6), 393–404. https://doi.org/10.3851/imp3331
Vannappagari, Vani, Leigh Ragone, Cassidy Henegar, Jean van Wyk, Dannae Brown, James Demarest, Romina Quercia, et al. “Prevalence of Pretreatment and Acquired HIV-1 Mutations Associated with Resistance to Lamivudine or Rilpivirine: A Systematic Review.” Antiviral Therapy 24, no. 6 (August 2019): 393–404. https://doi.org/10.3851/imp3331.
Vannappagari V, Ragone L, Henegar C, van Wyk J, Brown D, Demarest J, et al. Prevalence of Pretreatment and Acquired HIV-1 Mutations Associated with Resistance to Lamivudine or Rilpivirine: A Systematic Review. Antiviral Therapy. 2019 Aug;24(6):393–404.
Vannappagari, Vani, et al. “Prevalence of Pretreatment and Acquired HIV-1 Mutations Associated with Resistance to Lamivudine or Rilpivirine: A Systematic Review.” Antiviral Therapy, vol. 24, no. 6, SAGE Publications, Aug. 2019, pp. 393–404. Crossref, doi:10.3851/imp3331.
Vannappagari V, Ragone L, Henegar C, van Wyk J, Brown D, Demarest J, Quercia R, Clair MS, Underwood M, Gatell JM, de Ruiter A, Aboud M. Prevalence of Pretreatment and Acquired HIV-1 Mutations Associated with Resistance to Lamivudine or Rilpivirine: A Systematic Review. Antiviral Therapy. SAGE Publications; 2019 Aug;24(6):393–404.

Published In

Antiviral Therapy

DOI

EISSN

2040-2058

ISSN

1359-6535

Publication Date

August 2019

Volume

24

Issue

6

Start / End Page

393 / 404

Publisher

SAGE Publications

Related Subject Headings

  • Virology
  • 1108 Medical Microbiology
  • 1103 Clinical Sciences
  • 0605 Microbiology